Related references
Note: Only part of the references are listed.Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling
Robert R. McWilliams et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK
Anne E. Cust et al.
JOURNAL OF MEDICAL GENETICS (2011)
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk
Amy L. Sherborne et al.
NATURE GENETICS (2010)
Population-based, Case-Control-Family Design to Investigate Genetic and Environmental Influences on Melanoma Risk Australian Melanoma Family Study
Anne E. Cust et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
HEAD AND NECK SQUAMOUS CELL CARCINOMA IN FAMMM SYNDROME
Vladimir Vinarsky et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families
Femke A. de Snoo et al.
CLINICAL CANCER RESEARCH (2008)
Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes
Susanne Magnusson et al.
FAMILIAL CANCER (2008)
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
Alisa M. Goldstein et al.
CANCER RESEARCH (2006)
The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma:: An international population-based study
Marianne Berwick et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
CDKN2A common variant and multi-organ cancer risk -: a population-based study
T Dedniak et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma
Colin B. Begg et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample
CB Begg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
A common variant of CDKN2A (p16) predisposes to breast cancer
T Debniak et al.
JOURNAL OF MEDICAL GENETICS (2005)
Extending the p16-Leiden tumour spectrum by respiratory tract tumours
RA Oldenburg et al.
JOURNAL OF MEDICAL GENETICS (2004)
Prospective risk of cancer in CDKN2A germline mutation carriers
AM Goldstein et al.
JOURNAL OF MEDICAL GENETICS (2004)
Validation of family history data in cancer family registries
A Ziogas et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2003)
A marginal likelihood approach for estimating penetrance from kin-cohort designs
N Chatterjee et al.
BIOMETRICS (2001)
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
Å Borg et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations
AM Goldstein et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
